Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Evidence-based Medicine (EBM) is feared to become a kind of cook-book medicine that has nothing to do with the traditional skills and ethics.This volume shows the contribution EBM makes and might make to medical practice and health policy. It describes as many viewpoints as possible with a focus on the ethical issues that are at stake in this process.It shows how EBM has developed from an internal medical issue to an instrument for health policy. It is the outcome of the European Project "Ethical Issues of Evidence Based Practice in Medicine and Health Care" and gives insight into the ethical background of the debate on the role of EBM in various areas of medicine, including clinical practice, medical education, medical research, health policy and medical sociology.About the AuthorR. ter Meulen, PhDFull professor & Director of the Institute for Bioethics Department of Health Care Studies, Section Health Ethics and PhilosophyInstitute for Bioethicshttp://www.zw.unimaas.nl/gew/staffresdescr/ruudtermeulen.htmProf. Ruud ter Meulen (1952) is psychologist and ethicist. He is Director of the Institute for Bioethics and Professor for Philosophy and Ethics at the University of Maastricht and in Maastricht. The main research areas of Prof. Ter Meulen are the promoting of autonomy in the care for dependent elderly, resource allocation (particularly in regard to elderly care), medical ethics committees, ethical pluralism and the problem of consensus. Prof. Ter Meulen has directed several international projects. He was co-director of the International Project 'Care for the Elderly: Goals and Priorities' (1991-1994), a joint project with the Hastings Centre and sponsored by the European Union. He was coordinator of several European projects: the BIOMED project (1993-1995) 'Ethical Issues in the Research with Cognitively Impaired Elderly Subjects', the workpackage Ethical Issues and Quality of Life of the European Alzheimer Clearing House (EACH) project (1996-1997) and the project Ethical Issues of Elderly Care, which is part of the BIOMED project European Biomedical Ethics Practitioner Education (1996-1999) co-ordinated by Imperial College (UK). He was co-ordinator of the BIOMED 2 project 'Solidarity and care in the European Union' (1998-2000). He is coordinating two projects within the Fifth Framework. One of them is the project ‘Ethical Issues of genetics’ which is part of the TEMPE project (2000-2002), co-ordinated by Imperial College. The other one is the two-year project ‘Ethical Issues of Evidence Based Practice in Medicine and Health Care’ (EVIBASE) which finished in March 2003. Prof. Ter Meulen was principal coordinator of the EVIBASE project. He is partner and member of the core-group of the Project Bio-Technology-Ethics, coordinated by the University of Genoa (Prof. Celada), which develops a training course in ethics for PhD students in the field of biotechnology. Prof. Ter Meulen is the coordinator of NOMET, the national training course for members of ethics committees on the ethical and legal issues of medical research with human beings. This project is sponsored by the Ministry of Health and promoted by the Central Committee for Medical Research with Human Persons (CCMO).

WB 102 Clinical medicine --- Evidence-Based Practice --- Ethics, Clinical --- Medicine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Clinical Evidence summarises the current state of knowledge and uncertainty about the prevention and treatment of clinical conditions, based on thorough searches and appraisal of the literature. It is neither a textbook of medicine nor a set of guidelines. It describes the best available evidence from systematic reviews, RCTs and observational studies where appropriate, and if there is no good evidence it says so.Clinical Evidence is intended as a tool for clinicians, and thereby patients, to help them make evidence-based healthcare decisions. Our task is to provide information that is as accessible as possible without undue simplification. We aim to support the partnership between clinicians and patients that lies at the heart of good health care. We are working towards a future in which the information in Clinical Evidence can be personalised and synchronised with the electronic patient record, acknowledging that most interactions between patients and clinicians are complex and that 'evidence' is only one part of the equation.

WB 102 Clinical medicine --- Clinical Medicine --- Evidence-Based Medicine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Het toepassen van “evidence-based medicine” in de praktijk is niet evident. Zo worden bijvoorbeeld het voor acute keelpijn nog altijd te vaak antibiotica voorgeschreven. Wat verwachten patiënten eigenlijk van hun dokter en wat denken artsen hierover? Welke belemmeringen ervaren artsen bij het toepassen van EBM richtlijnen? En wat zijn mogelijke oplossingen hiervoor? In dit beschrijvend onderzoek over de implementatie van evidence-based medicine in de huisartspraktijk worden artsen en patiënten aan het woord gelaten. Hoe artsen en patiënten communiceren is een belangrijke schakel bij het toepassen EBM guidelines in de praktijk. Conclusies en aanbevelingen worden geboden voor het beleid en professionele organisaties.

Evidence-Based Medicine --- Practice Guideline [Publication type] --- WB 102 Clinical medicine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"'Evaluating the impact of implementing Evidence-Based Practice' is the third of three books on implementing evidence based practice in the Evidence-based nursing series published jointly by Blackwell Publishing and Sigma Theta Tau International. 'Evaluation and outcome measures for evidence-based practice' addresses the means to rigorously identify, evaluate and assess the outcomes of implementation of evidence into practice. 'Evaluating the impact of implementing Evidence-Based Practice' provides practical and effective guidance on how to assess whether implementation was effective, the full range of issues to be considered when measuring the impact of implementation and the range of approaches which could be used. It stresses the importance of ensuring the long-term sustainability of improvements in care and of measuring the use of interventions and innovations, in order to effectively evaluate the impact on outcomes and. It examines the impact of implementation on economic outcomes and the outcomes of importance to different groups including service users, clinicians, managers and policy makers. The approaches outlined in each chapter are transferable across a range of international, professional and healthcare settings"--Provided by publisher.

Evidence-Based Practice --- Evaluation --- WB 102 Clinical medicine --- Health Status --- Health Status Indicators

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This bestselling pocket guide to the skills of evidence-based medicine succeeds in demystifying the terminology and processes in a handy and easy-to-follow format, all within the space of 100 pages. With an improved layout, this second edition of Evidence-based Medicine Toolkit offers more up-to-date guidance as well as new sections on important areas of research. New features of this second edition include:A box for each major database showing how to search the evidence, and highlighting the differences between them Flow charts for different study types New critical appraisal sections on qualitative research and economic evaluation Expanded list of EBM resources on the net.With these added features to make the job easier, the new Toolkit is now an even better companion for all health care professionals using evidence-based methodology in their research and practice.

Human medicine --- Evidence-Based Medicine --- methods --- PXL-Healthcare 2014 --- evidence-based practice --- klinisch redeneren --- WB 102 Clinical medicine